Evidence map›Paper›PMID 25328861›Full record

ArticleCurrent environmental health reports2014

Cardiovascular Events Following Smoke-Free Legislations: An Updated Systematic Review and Meta-Analysis.

Miranda R Jones, Joaquin Barnoya, Saverio Stranges, Lia Losonczy, Ana Navas-Acien

Open access · bronzeAbstract read
In one paragraph

Article in Current environmental health reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Smoking Bans and Circulatory System Disease Mortality Reduction in Macao (China): Using GRA Models.International journal of environmental research and public health · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Support for smoke-free public places among adults in four countries in sub-Saharan Africa.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Article
  16. Article
  17. Analysis of non-compliance with smoke-free legislation in Russia.International journal of public health · 2019
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Miranda R JonesJohns Hopkins University Bloomberg School of Public Health, Baltimore, MD.
Joaquin BarnoyaDivision of Public Health Sciences, Department of Surgery, Washington University in St. Louis, St. Louis MO.
Saverio StrangesDivision of Health Sciences, University of Warwick Medical School, Coventry, UK.
Lia LosonczyHighland Hospital of Alameda County, Oakland, CA.
Ana Navas-AcienJohns Hopkins University Bloomberg School of Public Health, Baltimore, MD.
Johns Hopkins University · USHighland Hospital · USUniversity of Warwick · GBWashington University in St. Louis · US

Funding

INSTITUTIONAL RESEARCH CANCER EPIDEMIOLOGY FELLOWSHIPT32CA009314 · NCI · JOHNS HOPKINS UNIVERSITY · PI Corinne E. Joshu, Meghan Bridgid Moran · 1985 to 2026
$11.2M
Race/Ethnicity, Menthol Cigarettes, and Biomarkers of Tobacco Use in the U.S.R03CA153959 · NCI · JOHNS HOPKINS UNIVERSITY · PI NAVAS-ACIEN, ANA · 2010 to 2011
$156k
NCI NIH HHS R03 CA153959NCI NIH HHS T32 CA009314
6 · The paper itself

Abstract

backgroundLegislations banning smoking in indoor public places and workplaces are being implemented worldwide to protect the population from secondhand smoke exposure. Several studies have reported reductions in hospitalizations for acute coronary events following the enactment of smoke-free laws.

objectiveWe set out to conduct a systematic review and meta-analysis of epidemiologic studies examining how legislations that ban smoking in indoor public places impact the risk of acute coronary events.

methodsWe searched MEDLINE, EMBASE, and relevant bibliographies including previous systematic reviews for studies that evaluated changes in acute coronary events, following implementation of smoke-free legislations. Studies were identified through December 2013. We pooled relative risk (RR) estimates for acute coronary events comparing post- vs. pre-legislation using inverse-variance weighted random-effects models.

resultsThirty-one studies providing estimates for 47 locations were included. The legislations were implemented between 1991 and 2010. Following the enactment of smoke-free legislations, there was a 12 % reduction in hospitalizations for acute coronary events (pooled RR: 0.88, 95 % CI: 0.85-0.90). Reductions were 14 % in locations that implemented comprehensive legislations compared to an 8 % reduction in locations that only had partial restrictions. In locations with reductions in smoking prevalence post-legislation above the mean (2.1 % reduction) there was a 14 % reduction in events compared to 10 % in locations below the mean. The RRs for acute coronary events associated with enacting smoke-free legislation were 0.87 vs. 0.89 in locations with smoking prevalence pre-legislation above and below the mean (23.1 %), and 0.87 vs. 0.89 in studies from the Americas vs. other regions.

conclusionThe implementation of smoke-free legislations was related to reductions in acute coronary event hospitalizations in most populations evaluated. Benefits are greater in locations with comprehensive legislations and with greater reduction in smoking prevalence post-legislation. These cardiovascular benefits reinforce the urgent need to enact and enforce smoke-free legislations that protect all citizens around the world from exposure to tobacco smoke in public places.

Indexed as

Cardiovascular diseasesLegislationsSmoke-free policyTobacco smoke pollution

Identifiers

PMID25328861
PMCPMC4198310
OpenAlexW2115962924

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.